Type of Posting: Revision Bulletin
Posting Date: 30–Oct–2009; updated 26–Feb–2010
Official Date: 01–Dec–2009
Expert Committee: Biopharmaceutics
In accordance with the Rules and Procedures of the 2005–2010 Council of Experts, the Biopharmaceutics Expert Committee has revised the monograph to include an accepted dissolution test 2 with different dissolution conditions approved by the U.S. Food and Drug Administration.
The Oxybutynin Chloride Tablets Revision Bulletin supersedes the currently official monograph and will be incorporated into the First Supplement to the USP 33–NF 28 Reissue.
Should you have any questions, please contact Margareth Marques, Ph.D. (301-816-8106 or mrm@usp.org).